Nuwellis (NUWE) Share-based Compensation (2011 - 2026)
Nuwellis' (NUWE) quarterly Share-based Compensation came in at $22000.0 in Q2 2026, up 29.41% on a YoY basis from $17000.0 in Q2 2025, and down 36.13% quarter-over-quarter from $34446.0 in Q1 2026.
Analysis
Nuwellis (NUWE) Share-based Compensation (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Share-based Compensation for 16 consecutive years, with $22000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation rose 29.41% year-over-year to $22000.0; the trailing twelve-month figure through Jun 2026 stood at $82000.0 (down 71.63% YoY), and the FY2025 full-year result was $127000.0, down 74.6% from the prior year.
- Share-based Compensation slipped to $22000.0 in Q2 2026 per NUWE's latest filing, from $34446.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $241000.0 in Q1 2022 and bottomed at $17000.0 in Q2 2025.
- Historically, Share-based Compensation has averaged $121858.1 across 5 years, with a median of $125000.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: Share-based Compensation sank 85.22% in 2025, then gained 29.41% in 2026.
- Over 5 years, Share-based Compensation stood at $165000.0 in 2022, then retreated by 4.85% to $157000.0 in 2023, then plunged by 33.76% to $104000.0 in 2024, then plunged by 76.92% to $24000.0 in 2025, then decreased by 8.33% to $22000.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $22000.0, $34446.0, and $24000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 34,446.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Sep 30, 2024 | 101,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Dec 31, 2023 | 157,000.00 |
| Sep 30, 2023 | 135,000.00 |
| Jun 30, 2023 | 197,000.00 |
| Mar 31, 2023 | 181,000.00 |
| Dec 31, 2022 | 165,000.00 |
| Sep 30, 2022 | 220,000.00 |
| Jun 30, 2022 | 236,000.00 |
| Mar 31, 2022 | 241,000.00 |
| Dec 31, 2021 | 321,000.00 |
| Sep 30, 2021 | 257,000.00 |